Nov 19, 2020

University of Utah to Speed Process of Bringing New Therapeutics to Patients

A new initiative aims to speed the process of bringing lifesaving medical discoveries made in University of Utah laboratories to new drugs and therapies for patients. The university’s Huntsman Cancer Institute, College of Pharmacy, and the Partners for Innovation, Ventures, Outreach & Technology Center have partnered to establish the University of Utah Therapeutics Accelerator Hub (U2TAH, or the Accelerator).

Nov 19, 2020

Scientists Discover Roles for a Cellular Motor in Cancer

Utah scientists have discovered new functions of a key cellular machine that regulates gene packaging and is mutated in 20% of human cancers. The study was published in print today in the journal Molecular Cell. Cairns and colleagues wanted to know how nucleosomes are moved along or removed from the DNA to unpackage and expose genes.

Nov 12, 2020

Huntsman Cancer Institute Researcher Receives National Cancer Clinical Investigator Team Leadership Award

Siwen Hu-Lieskovan, PhD, MD, physician scientist at Huntsman Cancer Institute and assistant professor of medicine at the University of Utah, has received the National Cancer Institute 2020 Cancer Clinical Investigator Team Leadership Award. The award recognizes outstanding clinical investigators at NCI-designated Cancer Centers who participate extensively in NCI-funded clinical trials, and whose leadership and activities promote a successful culture of collaborative clinical research.

Nov 10, 2020

HCI Researcher Receives Two Awards for Community Contributions and Neuroendocrine Tumor Research

Heloisa Soares, MD, PhD, a gastrointestinal and neuroendocrine tumor medical oncologist and researcher at Huntsman Cancer Institute and assistant professor of internal medicine at the University of Utah, received two awards from external organizations honoring her contributions to the field of cancer. Soares was named an Advocacy Champion by the American Society of Clinical Oncology. Soares also received the 2020 North American Neuroendocrine Tumor Society Theranostics Investigator Grant.

Oct 15, 2020

Huntsman Cancer Institute Leadership Announcement: Cairns Named Chief Academic Officer, Welm Named Senior Director of Basic Science

Today, Huntsman Cancer Institute at the University of Utah announced new leadership appointments for two long-standing cancer center members. Brad Cairns, PhD, has accepted an appointment as chief academic officer at HCI. Alana Welm, PhD, has accepted an appointment as senior director of basic science, a role previously held by Cairns. The new leadership appointments of Cairns and Welm are effective immediately.

Sep 29, 2020

5 For The Fight Announces Inaugural Class of Cancer Research Fellows at Huntsman Cancer Institute

5 For The Fight, a global movement inviting everyone to give $5 for the fight against cancer, today announced the inaugural recipients of the 5 For The Fight Cancer Research Fellowship in partnership with Huntsman Cancer Institute at the University of Utah.

Sep 22, 2020

Huntsman Cancer Institute Joins Nationwide Effort to Address COVID-19’s Impact on Cancer Prevention and Treatment

A group of 17 cancer centers around the country have banded together in a major new initiative to better understand how the COVID-19 pandemic is affecting cancer care and prevention.

Sep 16, 2020

To Reduce Colorectal Cancer Disparities among African American Men, More Intervention Research Is Urgently Needed

Out of any other racial group, African American men have the lowest five-year survival rate for colorectal cancer. Published research on effective strategies to increase screening for this group specifically are minimal. These findings were published today in a special health inequities and disparities issue of the journal PLOS ONE.